Yiling Pharmaceuticals will set up subsidiary for genetic testing, Ridge Biological Pharmaceutical Co.

Investment from Yiling will be 15 Mill. Yuan, and the focus will be on prognosis for various cancer risks.

CAS news release, Oct. 20, 2014

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny